Multiple modes of action, MRL tolerance exemption, and favorable environmental profile combine to deliver a powerful new tool for fruit, nut, vine and vegetable growers
DAVIS, Calif., August 27, 2014 — Marrone Bio Innovations, Inc. (MBI), (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that its VENERATETM Bioinsecticide is now registered in California. VENERATE is a new tool to help California growers control crop-damaging insect pests, fight the development of insect resistance and reduce pesticide residues on fruits and vegetables. more
DAVIS, Calif., July 29, 2014 —Marrone Bio Innovations, Inc. (NASDAQ: MBII), a provider of bio-based pest management and plant health products for the agricultural and water treatment markets, announced today that it will release its earnings results for the second quarter ended June 30, 2014 on Thursday, August 7, 2014 after the market closes.
>> Link to full announcement
Joint Discovery Efforts to Lead to Novel Insect Control Solutions
REHOVOT, Israel and DAVIS, California – July 22, 2014 – Evogene Ltd. (NYSE; TASE: EVGN), a leading plant genomics company specializing in enhancing crop productivity for the food, feed and biofuel industries, and Marrone Bio Innovations Inc. (MBI), (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, announced today the signing of a multiyear collaborative agreement targeting the joint discovery of novel modes of biological action for insect control, followed by the development and commercialization of new insect control products by each of the companies. more
DAVIS, Calif., July 14, 2014 — Marrone Bio Innovations, Inc. (MBI)[NASDAQ: MBII], a leading global provider of bio-based pest management and plant health products is pleased to announce the appointment of George Kerckhove to its Board of Directors.
Mr Kerckhove’s most recent professional experience included over 12 years with American Standard Companies, where he served as VP and Chief Financial Officer, Executive VP and Global Sector Manager of 21 countries and President and General Manager of the European Division. Prior to that, he served in a variety of positions over a 25 year tenure with The Trane Company in LaCrosse, WI, from Product Manager to VP and General Manager of the Process Equipment Division, and finally Executive VP and General Manager of both the US and International Commercial Equipment Divisions. more
The approved projects involve innovations in the areas of 3D Printing, Agro-technology, Information Security, Homeland Security and others
TEL AVIV, Israel, July 8, 2014 /PRNewswire/ –
During its meeting on June 26, 2014, held in Washington D.C., the Board of Governors of the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation, approved $8.9 million in funding for eleven new projects between Israeli and American companies. In addition to the grants from BIRD, the projects will access private sector funding, boosting the total value of all projects to approximately $25 million.
The BIRD Foundation promotes collaboration between Israeli and American companies in various technological fields for the purpose of joint product development. In addition to providing conditional grants of up to $1 million for approved projects, the Foundation assists by working with companies to identify potential strategic partners and facilitate introductions. more
Biological product for controlling zebra and quagga mussels provides environmentally responsible alternative to potash and copper-based products for open water applications
DAVIS, Calif., July 8, 2014 – Marrone Bio Innovations, Inc. (MBI) [Nasdaq: MBII], a leading global provider of bio-based pest management and plant health products announced today that the U.S. Environmental Protection Agency (EPA) has approved Zequanox for open water use to combat invasive zebra and quagga mussels in lakes, rivers, recreation areas and other open bodies of water. more
BANGOR, MI., July 2, 2014 — Marrone Bio Innovations, Inc. (MBI)(Nasdaq: MBII), a leading global provider of bio-based pest management and plant health products, celebrated the official opening of its Marrone Michigan Manufacturing (M3) facility yesterday with a ribbon cutting ceremony and plant tours.
The M3 facility is a wholly-owned subsidiary of MBI. Acquired in July 2012, the original site included an existing building of 11,400 square feet and 12 acres of land. It contained the infrastructure needed for planned manufacturing processes and provided ready access to transportation services while being ideally located in an area with a highly skilled, educated workforce for filling needed technical, operational and management positions.
Photo from left to right: State Senator John Proos, State Representative Aric Nesbitt, Administrator Lillian Salerno, USDA Rural Business-Cooperative Service, Pam Marrone, CEO Marrone Bio Innovations, US Senator Debbie Stabenow, Chairwoman of the US Senate Agriculture Committee, Jim Turner, State Director USDA-Rural Development, State Senator Tanya Shuitmaker, Mayor Nick Householder, Bangor, Michigan
The first phase of construction at the M3 plant enlarged the facility’s size by 6,600 square feet, adding fermentation capacity. Phase 2 and Phase 3 expansions are planned through 2017 and will amplify capacity to meet manufacturing needs for the growing MBI product family. more